Home › Obesity › North Carolina › Wilmington
Pag-aaral pangklinika para sa Obesity sa Wilmington, NC
Isang pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Wilmington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 2
- Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Nagre-recruitPhase 3
- Accellacare - Wilmington, Wilmington
- Jeffrey Coleman, OD, Wilmington
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Nagre-recruitPhase 2
- TMA Headlands, Wilmington
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Nagre-recruitPhase 3
- Accellacare and KDCILM, LLC, Wilmington
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Nagre-recruitPhase 3
- Accellacare and KDCILM, LLC, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Nagre-recruitPhase 3
- Accellacare - Wilmington - 1917 Tradd Court, Wilmington
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- Trial Management Associates - Wilmington - Floral Parkway, Wilmington
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Nagre-recruitPhase 3
- Accellacare of Wilmington, Wilmington
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Nagre-recruitPhase 3
- KDCILM, LLC & Accellacare US, Inc., Wilmington
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Nagre-recruitPhase 3
- Accellacare Research of Wilmington, Wilmington
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Nagre-recruitPhase 3
- Accellacare Wilmington, Wilmington
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Nagre-recruitPhase 3
- ACCOMPLISH-1 Research Site, Wilmington
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Nagre-recruitPhase 2
- Accellacare of Wilmington, Wilmington
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Nagre-recruitPhase 3
- Accellacare and KDCILM, LLC, Wilmington
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
Nagre-recruitPhase 1
- Accellacare, Wilmington
Pag-aaral para sa Obesity sa ibang lungsod
- Houston, TX43 pag-aaral
- Chicago, IL41 pag-aaral
- New York City, NY40 pag-aaral
- San Antonio, TX40 pag-aaral
- Washington, DC33 pag-aaral
- Orlando, FL32 pag-aaral
- Dallas, TX30 pag-aaral
- Boston, MA28 pag-aaral
- Las Vegas, NV27 pag-aaral
- Miami, FL27 pag-aaral
- Baltimore, MD26 pag-aaral
- Jacksonville, FL25 pag-aaral
Iba pang pag-aaral sa Wilmington
- Overweight11 pag-aaral
- Type 2 Diabetes8 pag-aaral
- Pagkabigo ng Puso6 pag-aaral
- Ulcerative Colitis4 pag-aaral
- Cholesterol3 pag-aaral
- Sakit sa Puso at Ugat ng Dugo3 pag-aaral
- Mataas na Presyon ng Dugo3 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.